Clinical Trial Update: Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating olfactory deficits and donepezil treatment in cognitively impaired elderly; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Phase 4 | Status: COMPLETED | Results posted: 2020-07-13